OP-EHEA191011 Online 2313..2340
European Heart Journal (2020) 41, 2313–2330 CURRENT OPINION doi:10.1093/eurheartj/ehz962 Translational medicine Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, Downloaded from https://academic.oup.com/eurheartj/article-abstract/41/24/2313/5735221 by University of Glasgow user on 13 July 2020 genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Jan Bore´n1†, M. John Chapman2,3*†, Ronald M. Krauss4, Chris J. Packard 5, Jacob F. Bentzon 6,7, Christoph J. Binder8, Mat J. Daemen 9, Linda L. Demer 10,11,12, Robert A. Hegele 13, Stephen J. Nicholls14, Børge G. Nordestgaard15, Gerald F. Watts16,17, Eric Bruckert18, Sergio Fazio19, Brian A. Ference20,21,22, Ian Graham23, Jay D. Horton24,25, Ulf Landmesser26,27, Ulrich Laufs28, Luis Masana29, Gerard Pasterkamp 30, Frederick J. Raal 31, Kausik K. Ray32, Heribert Schunkert33,34, Marja-Riitta Taskinen35, Bart van de Sluis36, Olov Wiklund 1, Lale Tokgozoglu 37, Alberico L. Catapano38, and Henry N. Ginsberg39 1Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden; 2Endocrinology- Metabolism Division, Pitie´-Salpeˆtrie`re University Hospital, Sorbonne University, Paris, France; 3National Institute for Health and Medical Research (INSERM), Paris, France; 4Department of Atherosclerosis Research, Children’s Hospital Oakland Research Institute and UCSF, Oakland, CA 94609, USA; 5Institute of Cardiovascular
[Show full text]